Lushang Freda Pharmaceutical Co (SHSE:600223) YoY EPS Growth : -53.85% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Lushang Freda Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Mar. 2024 was -53.85%.

Lushang Freda Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.06.

Lushang Freda Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lushang Freda Pharmaceutical Co YoY EPS Growth Chart

Lushang Freda Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

112.50

85.29

-44.44

-88.57

650.00

Lushang Freda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															116.67	-50.00	200.00	163.64	-53.85

Lushang Freda Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Lushang Freda Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(0.3	-	0.04)	/	\| 0.04 \|
=	650.00 %

Lushang Freda Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(0.06	-	0.13)	/	\| 0.13 \|
=	-53.85 %

Lushang Freda Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Lushang Freda Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » YoY EPS Growth

Traded in Other Exchanges

N/A

Address

No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN

Website

http://www.lshzy.com.cn

Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.

Executives

Li Hang	senior management
Yin Wei	Directors, senior managers
Shao Zhao Wei	senior management
Wang Zhong Wu	senior management
Dong Hong Lin	Director
Zhou Hong Bo	senior management
Li Lu	senior management
Liu Zeng Wei	senior management
Zhang Quan Li	senior management
Xu Tao	senior management
Ju Hai Bo	Director
Zhao Xi Liang	Director
Pi Xi Cai	Supervisors

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines